[1] |
WIJDICKS EF. Hepatic Encephalopathy[J]. N Engl J Med, 2016, 375(17):1660-1670. doi: 10.1056/NEJMra1600561
|
[2] |
王丰姣, 柳明江, 吴瑞红, 等.肝性脑病患者短期预后的相关危险因素分析[J].临床肝胆病杂志, 2017, 33(4):711-714. DOI: 10.3969/j.issn.1001-5256.2017.04.022.WANG FJ, LIU MJ, WU RH, et al. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. J Clin Hepatol, 2017, 33(4):711-714. DOI: 10.3969/j.issn.1001-5256.2017.04.022.
|
[3] |
LEISE MD, POTERUCHA JJ, KAMATH PS, et al. Management of hepatic encephalopathy in the hospital[J]. Mayo Clin Proc, 2014, 89(2):241-253. DOI: 10.1016/j.mayocp.2013.11.009.
|
[4] |
HASSANEIN T. Current state of knowledge of hepatic encephalopathy (part Ⅳ): management of hepatic encephalopathy by liver support systems[J]. Metab Brain Dis, 2017, 32(2):303-306. DOI: 10.1007/s11011-016-9911-1.
|
[5] |
KODALI S, MCGUIRE BM. Diagnosis and management of hepatic encephalopathy in fulminant hepatic failure[J]. Clin Liver Dis, 2015, 19(3):565-576. DOI: 10.1016/j.cld.2015.04.006.
|
[6] |
O'GRADY J. Liver transplantation for acute liver failure[J]. Best Pract Res Clin Gastroenterol, 2012, 26(1):27-33. DOI: 10.1016/j.bpg.2012.01.012.
|
[7] |
OLSON JC. Acute-on-chronic liver failure: management and prognosis[J]. Curr Opin Crit Care, 2019, 25(2):165-170. DOI: 10.1097/MCC.0000000000000595.
|
[8] |
WEISSENBORN K. Minimal/covert hepatic encephalopathy-impact of comorbid conditions[J]. J Clin Exp Hepatol, 2019, 9(1):109-111. DOI: 10.1016/j.jceh.2018.08.010.
|
[9] |
DEMETRIOU AA, BROWN RS JR, BUSUTTIL RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure[J]. Ann Surg, 2004, 239(5):660-670. doi: 10.1097/01.sla.0000124298.74199.e5
|
[10] |
KARVELLAS CJ, TODD STRAVITZ R, BATTENHOUSE H, et al. Therapeutic hypothermia in acute liver failure: a multicenter retrospective cohort analysis[J]. Liver Transpl, 2015, 21(1):4-12. DOI: 10.1002/lt.24021.
|
[11] |
WONG RJ, AGUILAR M, GISH RG, et al. The impact of pretransplant hepatic encephalopathy on survival following liver transplantation[J]. Liver Transpl, 2015, 21(7):873-880. DOI: 10.1002/lt.24153.
|
[12] |
李海波, 符洪源, 陆桐宇, 等.肝移植领域2017年度重要进展盘点[J].器官移植, 2018, 9(1):41-50, 82. DOI: 10.3969/j.issn.1674-7445.2018.01.006.LI HB, FU HY, LU TY, et al. Summary of important research on liver transplantation in 2017[J]. Organ Transplant, 2018, 9(1):41-50, 82. DOI: 10.3969/j.issn.1674-7445.2018.01.006.
|
[13] |
邓小红, 张倩倩, 蔡燕, 等.肝癌患者肝移植前外周血免疫表型分析[J].中山大学学报(医学科学版), 2018, 39(2):178-185, 226. http://d.old.wanfangdata.com.cn/Periodical/zsykdxxb201802003DENG XH, ZHANG QQ, CAI Y, et al. Detection of immune cell subsets of peripheral blood in hepatocellular carcinoma before liver transplantation[J]. J Sun Yat-sen Univ(Med Sci), 2018, 39(2):178-185, 226. http://d.old.wanfangdata.com.cn/Periodical/zsykdxxb201802003
|
[14] |
MURALI AR, CHANDRA S, STEWART Z, et al. Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management[J]. Transplantation, 2016, 100(12):2661-2670. doi: 10.1097/TP.0000000000001406
|
[15] |
CHENG CN, LIN SW, WU CC. Early linezolid-associated lactic acidosis in a patient with Child's class Cliver cirrhosis and end stage renal disease[J]. J Infect Chemother, 2018, 24(10):841-844. DOI: 10.1016/j.jiac.2018.02.002.
|
[16] |
BAEK SD, JANG M, KIM W, et al. Benefits of intraoperative continuous renal replacement therapy during liver transplantation in patients with renal dysfunction[J]. Transplant Proc, 2017, 49(6):1344-1350. DOI: 10.1016/j.transproceed.2017.03.094.
|
[17] |
PANTHAM G, POST A, VENKAT D, et al. A new look at precipitants of overt hepatic encephalopathy in cirrhosis[J]. Dig Dis Sci, 2017, 62(8):2166-2173. DOI: 10.1007/s10620-017-4630-y.
|
[18] |
LEE SM, SON YK, KIM SE, et al. Clinical outcomes of peritoneal dialysis in end-stage renal disease patients with liver cirrhosis: a propensity score matching study[J]. Perit Dial Int, 2017, 37(3):314-320. DOI: 10.3747/pdi.2016.00129.
|
[19] |
WAGHRAY A, WAGHRAY N, KANNA S, et al. Optimal treatment of hepatic encephalopathy[J]. Minerva Gastroenterol Dietol, 2014, 60(1):55-70. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=97aa0ef537d013ef24b4709c3938c4ac
|
[20] |
SHAW J, BAJAJ JS. Covert hepatic encephalopathy: can my patient drive? [J]. J Clin Gastroenterol, 2017, 51(2):118-126. DOI: 10.1097/MCG.0000000000000764.
|
[21] |
BRESCIA MD, MASSAROLLO PC, IMAKUMA ES, et al. Prospective randomized trial comparing hepatic venous outflow and renal function after conventional versus piggyback liver transplantation[J]. PLoS One, 2015, 10(6):e0129923. DOI: 10.1371/journal.pone.0129923.
|